Topiroxostat (INN; trade names Topiloric, Uriadec) is a drug for the treatment of gout and hyperuricemia.

[1] It was approved for use in Japan in June 2013.

[1] Topiroxostat is a xanthine oxidase inhibitor which reduces serum urate levels.

[2] This drug article relating to the musculoskeletal system is a stub.

You can help Wikipedia by expanding it.